Table 2.
Clinical outcomes for the analyzed COVID-19+ blood samples
Factor | Value |
---|---|
Thrombotic complication, n (%) | 11 (23.9%) |
Mortality, n (%) | 6 (13%) |
Admitted to ICU, n (%) | 11 (23.9%) |
Intubated & mechanically ventilated, n (%) | 7 (15.2%) |
Vasopressor infusion, n (%) | 7 (15.2%) |
Acute kidney injury, n (%) | 24 (52.1%) |
Bacterial pneumonia, n (%) | 13 (28.3%) |
Bacterial culture, n (%) | 29 (63%) |